Webinar: What is the role of calprotectin in COVID-19

12. Apr 2021 | 5 min read

Webinar: What is the role of calprotectin in COVID-19

The role of calprotectin in COVID-19

Clinical studies report increased levels of calprotectin in patients with severe SARS-CoV-2 infection, as well as identifying the ability of calprotectin to differentiate between mild and severe forms of the disease and its capability to predict the need for mechanical ventilation and mortality1-6. This is valuable information that can help hospitals to better allocate essential resources that are often in limited supply.

In this webinar Gentian's VP Clinical Affairs Dr Aleksandra Havelka will give an introduction to the biomarker calprotectin in relation to severe COVID-19 and the hyper-inflammatory response, before she will go through several clinical studies discussing the value of calprotectin in COVID-19.

Watch webinar now

 

GCAL and COVID-19 9110v01


OR WATCH ON
YOUTUBE


GCAL® - Gentian's calprotectin immunoassay - early access to results

Gentian’s Calprotectin Immunoassay GCAL® is a Particle-Enhanced Turbidimetric Immunoassay (PETIA), and is therefore rapidly performed in only 10 minutes, making it extra beneficial when it is critical to get fast access to the results.

 

Learn more about GCAL® - contact us now

Do you have questions about GCAL®  or calprotectin's role in COVID-19 send an email to marketing@gentian.com or fill out the form below:

 

New call-to-action

 

References:

  1. Shi H, Zuo Y, Yalavarthi S et al. Neutrophil calprotectin identifies severe pulmonary disease in COVID-19. Journal of Leukocyte Biology. 2020;n/a(n/a).
  2. Luis García de Guadiana R, Mulero MDR et al. Circulating levels of GDF-15 and calprotectin for prediction of in-hospital mortality in COVID-19 patients: A case series. J Infect. 2020:S0163-4453(20)30543-0.
  3. Udeh R, Advani S, de Guadiana Romualdo LG, Dolja-Gore X. Calprotectin, an Emerging Biomarker of Interest in COVID-19: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2021;10(4).

You may also read


Meet us in 2021 - AACC and EUROMEDLAB

Jul 23, 2021

Meet us in 2021 - AACC and EUROMEDLAB

We are happy to announce that Gentian will be exhibiting at the AACC in Atlanta in September and at..

Diagnostic Efficiency: Newsletter July 2021

Jul 07, 2021

Diagnostic Efficiency: Newsletter July 2021

We are happy to announce that Gentian will be exhibiting at the AACC in Atlanta this September and at..

Gentian Diagnostics listed on the Oslo Stock Exchange

Jun 25, 2021

Gentian Diagnostics listed on the Oslo Stock Exchange

Gentian Diagnostics was today listed on the Oslo Stock Exchange “We made a promise to our shareholders when..